Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10293917 | 0.96 | ESR1 (0.48) | ESR1CA9CA1CA2CA12 | |
| SCHEMBL10293951 | 0.96 | DNASE1L3 (0.45) | ESR1DNASE1L3PRMT1CA9CA1 | |
| SCHEMBL13024599 | 0.92 | ESR1 (0.43) | ESR1DNASE1L3PRMT1CA9CA1 | |
| SCHEMBL10293902 | 0.91 | ESR1 (0.47) | ESR1DNASE1L3PRMT1CA9CA1 | |
| SCHEMBL10293935 | 0.91 | ESR1 (0.48) | ESR1CA9CA1CA2CA12 | |
| SCHEMBL14115547 | 0.91 | ESR1 (0.43) | ESR1DNASE1L3PRMT1CA9CA1 | |
| SCHEMBL13024595 | 0.88 | ESR1 (0.48) | ESR1CA9CA1CA2CA12 | |
| SCHEMBL13024605 | 0.88 | DNASE1L3 (0.45) | ESR1DNASE1L3PRMT1CA9CA1 | |
| SCHEMBL14415022 | 0.88 | ESR1 (0.47) | ESR1CA9CA1CA2CA12 | |
| SCHEMBL14415034 | 0.87 | DNASE1L3 (0.44) | ESR1DNASE1L3PRMT1CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100280246-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | APPLERA CORPORATION (US) | 2010-11-04 | — | — | US | disclosed |
| US-7825237-B2 | Oligonucleotides and analogs labeled with energy transfer dyes | APPLIED BIOSYSTEMS, LLC (US) | 2010-11-02 | — | — | US | disclosed |
| US-20100029923-A1 | OLIGONUCLEOTIDES AND ANALOGS LABELED WITH ENERGY TRANSFER DYES | Life Technologies Corporation (US) | 2010-02-04 | — | — | US | disclosed |
| US-7399854-B2 | Regents labeled with energy transfer dyes | APPLERA CORPORATION (US) | 2008-07-15 | — | — | US | disclosed |
| US-20070161026-A1 | REGENTS LABELED WITH ENERGY TRANSFER DYES | APPLERA CORPORATION (US) | 2007-07-12 | — | — | US | disclosed |
| US-20070154927-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | APPLERA CORPORATION (US) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280246-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | SLC25A21, ZCCHC8, ZDHHC7 | ESR1 2242/4885DNASE1L3 3657/4885PRMT1 1266/4885 |
| US-20100029923-A1 | OLIGONUCLEOTIDES AND ANALOGS LABELED WITH ENERGY TRANSFER DYES | RBM28, TRDMT1, RPS28 | ESR1 1970/4885DNASE1L3 1414/4885PRMT1 1751/4885 |
| US-20070161026-A1 | REGENTS LABELED WITH ENERGY TRANSFER DYES | SOAT1, GFPT1, CBR3 | ESR1 1296/4885DNASE1L3 4166/4885PRMT1 902/4885 |
| US-20070154927-A1 | ENERGY TRANSFER DYES WITH ENHANCED FLUORESCENCE | SLC25A21, ZCCHC8, SLC25A1 | ESR1 2046/4885DNASE1L3 3684/4885PRMT1 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.